Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

A Prospective Cohort Study of Clinical and Process Outcomes of Older Adults That Transition Through the Geriatric Emergency Medicine Unit(GEM-U)

NCT07237334 · tracked via the Priya Life Science Ireland tracker
Phase
Observational
Started
2025-02-10
Last updated
2025-11-19

Condition(s) studied

Frailty

Study summary

This study will characterise the patients using the Geriatric Emergency Medicine Unit, a unit which provides specialist care for patients aged 75 years and older attending the emergency department. It will examine how this specialist care impacts their health in terms of a number of different outcomes, such as; function, quality of life and health care usage; for example admission to the acute hospital.

Eligibility

Sex
ALL
Min age
75 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Older adults aged ≥75 years * Manchester Triage System category 2-5 * Screen positive for risk of adverse outcomes after ED visit (≥ 2 on ISAR screening tool) * Presenting with a medical condition * Reviewed by the Older Persons Integrated Care Team Exclusion Criteria: * Patients presenting with a non-medical issue including major trauma or hip fracture * Patients presenting with acute stroke or transient ischaemic attack * Patients more appropriate to another alternative pathway e.g. deep vein thrombosis pathway, low risk chest pain pathway * Patients with acute coronary syndrome or unstable arrthymia * Patients requiring care in the resuscitation room * Patients with head injury (unless appropriate assessment and management has been fully completed by ED team) * Patients with possible spinal injury (unless appropriate assessment and management has been fully completed by ED/orthopaedic team) * Patients with low Glasgow Coma Scale * Other exclusions at the discretion of the Older Persons Integrated Care team depending on team capacity and expertise * Exclusion criteria as set out above, are in line with those set out in the UHL Operating Policy of the Older Persons Integrated Care Team.

Primary outcome measure(s)

  • Our primary outcome is incidence of hospital admission at index GEM-U presentation — Patients are followed at 30 days and 6 months
    Patients who attend GEM-U and have an acute hospital admission at this time

Trial sites (1)

FacilityCityRegionStatus
University Hospital Limerick Limerick Munster Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07237334 on ClinicalTrials.gov ↗ ← All trials in Ireland